Search

Zai Lab Ltd ADR

Closed

SectorHealthcare

25.04 -1.14

Overview

Share price change

24h

Current

Min

25.33

Max

26.35

Key metrics

By Trading Economics

Income

191K

-51M

Sales

6.7M

106M

EPS

-0.46

Profit margin

-47.808

Employees

1,784

EBITDA

-2.1M

-46M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+54.78% upside

Dividends

By Acuity

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

892M

2.9B

Previous open

26.18

Previous close

25.04

News Sentiment

By Acuity

38%

62%

94 / 339 Ranking in Healthcare

Zai Lab Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 wrz 2026, 23:56 UTC

News

Korn Ferry's Board declared a quarterly cash dividend of $0.55 per share, payable October 15. Shares traded roughly flat in after-market hours.

8 wrz 2026, 23:56 UTC

Social Media
News

Chevron Corp shares are higher in after-market hours following a report on declining OECD strategic petroleum reserves, which may impact oil prices and benefit the company.

8 wrz 2026, 23:46 UTC

News
Social Media

Warner Bros Discovery Inc. shares are higher in after-market hours following Paramount Skydance's court filings on merger progress, indicating potential $1.88 billion impact.

8 wrz 2026, 23:41 UTC

News

BJ's Restaurants shares are trading lower in after-market hours following a presentation at the Barclays Consumer Staples Conference focused on a strategic reset.

8 wrz 2026, 23:41 UTC

News

Boston Beer Company appointed Allison Stransky as Chief Marketing Officer, effective October 12, 2026. Shares are trading higher in after-market hours.

8 wrz 2026, 23:41 UTC

News

Goldman Sachs has agreed to acquire NEOS Investments for $2.25 billion, with shares trading lower in after-market hours following the announcement.

8 wrz 2026, 23:36 UTC

News
Correlated Moves

Piper Sandler initiated coverage of Quanta Services with an Overweight rating. Shares rose in after-market trading, closing at $624.41.

8 wrz 2026, 23:36 UTC

News

Shutterstock Inc appointed three new board members to enhance governance. Shares are trading higher after the announcement of Timothy Adams, Matthew Salzberg, and Michael Thompson.

8 wrz 2026, 23:36 UTC

News

Air Products and Chemicals reported stronger third-quarter profitability, boosting full-year guidance. Shares traded higher in after-market hours following the results.

8 wrz 2026, 23:31 UTC

News

NetApp shares are trading higher in after-market hours following CEO George Kurian's discussion at the Goldman Sachs Communacopia + Technology Conference.

8 wrz 2026, 23:31 UTC

News

Estee Lauder Companies announced expanded leadership roles for Brian Franz and Amber English. Shares traded lower during after-market hours following the news.

8 wrz 2026, 23:21 UTC

News

Prestige Consumer Healthcare Inc shares are lower in after-market trading amid geopolitical tensions and inflation concerns affecting market sentiment across sectors.

8 wrz 2026, 23:21 UTC

News

Target Corp shares are higher in after-market trading, supported by recent turnaround efforts despite an analyst downgrade to a hold rating.

8 wrz 2026, 23:21 UTC

News

Tapestry Inc gains in after-market trading, with a market cap of $23.69 billion. A $100 investment five years ago is now worth approximately $290.54.

8 wrz 2026, 23:16 UTC

News

Stanley Black & Decker shares are higher in after-market trading following the announcement of CEO Chris Nelson's upcoming presentation at a Morgan Stanley conference.

8 wrz 2026, 23:11 UTC

News

Travel + Leisure Co shares are higher in after-market hours following the announcement of CFO Erik Hoag's participation in a Goldman Sachs conference on September 14, 2026.

8 wrz 2026, 23:06 UTC

News

Lowe's CEO Marvin R. Ellison will participate in a Goldman Sachs conference on September 15, 2026. Shares are higher in after-market trading.

8 wrz 2026, 23:06 UTC

Social Media
News
Correlated Moves

Citigroup plans to offer instant cross-border payments using blockchain technology for Japanese firms. Shares are higher in after-market trading following the announcement.

8 wrz 2026, 23:06 UTC

Social Media
News

General Electric shares rise in after-market hours amid interest in strategic developments, including a $11.75 billion acquisition and potential valuation boost for Precision Castparts.

8 wrz 2026, 23:06 UTC

News

Eli Lilly's Mounjaro received FDA approval to reduce heart-attack and stroke risk in adults with type 2 diabetes. Shares advanced slightly in after-market trading.

8 wrz 2026, 23:06 UTC

News

NextEra Energy Inc. shares are trading higher in after-market hours as management announces investor meetings to discuss growth expectations and the Dominion Energy merger.

8 wrz 2026, 23:06 UTC

News

Merck & Co. shares are higher after Karim Mikhail's appointment to lead the FDA's Center for Biologics Evaluation and Research, boosting the company's regulatory reputation.

8 wrz 2026, 23:06 UTC

News

General Mills has filed an antitrust lawsuit against major U.S. sugar producers for alleged price collusion, with shares trading higher in after-market hours.

8 wrz 2026, 23:06 UTC

News

VICI Properties Inc. shares are trading higher in after-market hours following the release of its 2025-2026 Corporate Responsibility Report, highlighting sustainability efforts.

8 wrz 2026, 23:06 UTC

Event
News

Roivant Sciences Ltd shares are lower in after-market hours despite positive Phase 2 trial results for mosliciguat targeting pulmonary hypertension.

8 wrz 2026, 23:01 UTC

Social Media
News

AT&T's CEO highlights growth potential and $45B shareholder return plan at Goldman Sachs conference; shares rise in after-market hours.

8 wrz 2026, 23:01 UTC

News

Ares Capital Corp priced a $750 million public offering of unsecured notes, aiming to enhance financial flexibility. Shares are trading higher in after-market hours.

8 wrz 2026, 23:01 UTC

News

Constellation Brands plans to redeem $600 million in Senior Notes due 2027, contributing to a rise in shares during after-market trading.

8 wrz 2026, 23:01 UTC

Correlated Moves
News
Event
Social Media

Braze Inc shares fell sharply in after-hours trading despite strong second-quarter results, as weaker third-quarter EPS guidance raised investor concerns.

8 wrz 2026, 23:01 UTC

Social Media
News

GameStop shares fell in after-hours trading despite reporting adjusted EPS of $0.27 and raising its fiscal year 2026 EBITDA outlook to over $650 million.

Peer Comparison

Price change

Zai Lab Ltd ADR Forecast

Price Target

By TipRanks

54.78% upside

12 Months Forecast

Average 39.33 USD  54.78%

High 45 USD

Low 36 USD

Based on 3 Wall Street analysts offering 12 month price targets forZai Lab Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Sentiment

By Acuity

94 / 339 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat